CHICAGO (AP) -- A combination of drugs that acts as a sort of "smart bomb" against breast cancer cells without damaging healthy ones has undergone successful early testing.
In a key test involving nearly 1,000 women with very advanced disease, the experimental treatment extended by several months the time women lived without their cancer getting worse.
More importantly, the treatment seems likely to improve survival. After two years, 65 percent of women who received it were still alive versus 47 percent of those in a comparison group given two standard cancer drugs.
That margin fell just short of the very strict criteria researchers set for stopping the study and declaring the new treatment a winner. In fact, so many women on the new treatment are still alive that researchers cannot yet determine average survival for the group.
Doctors planned to report results at a cancer conference in Chicago.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to email@example.com. Please provide detailed information.